Cholangioscopy Market - Forecasts from 2025 to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,950	145 Pages	Knowledge Sourcing Intelligence LLP	January, 2025	KSIN20002782

Best Price Guarantee
Price	from $3,950
Length	145 Pages
Publisher	Knowledge Sourcing Intelligence LLP
Published Date	January, 2025
SKU	KSIN20002782

The cholangioscopy market is estimated to grow at a CAGR of 7.19%, attaining US$14.820 billion by 2030, from US$10.476 billion in 2025.
Cholangioscopy, also known as peroral cholangioscopy (POC), is a minimally invasive procedure used primarily to evaluate and diagnose conditions affecting the bile ducts. This technique allows for direct visual examination of the bile ducts and can also facilitate simultaneous therapeutic interventions. Cholangioscopy offers numerous advantages to the healthcare sector, including the ability to identify and address blockages in the liver, pancreas, and biliary systems, as well as detect cancers within these ducts.The global cholangioscopy market is projected to experience significant growth, largely driven by the rising incidence of bile duct cancer. Cholangioscopy plays a vital role in the detection and monitoring of this type of cancer. Additionally, the increasing elderly population is expected to further boost market growth. However, challenges such as the potential for side effects and the high costs associated with cholangioscopy procedures may hinder market expansion.
Drivers of the Cholangioscopy Market

Rising Incidence of Bile Duct Cancer: A primary factor driving growth in the global cholangioscopy market is the increasing number of bile duct cancer cases. Bile duct cancer, or cholangiocarcinoma, is a rare yet aggressive form of cancer that predominantly affects older individuals. Cholangioscopy is crucial for detecting and assessing malignant lesions, allowing for precise localization of cancer cells. The procedure also facilitates specimen collection for further analysis, which can enhance treatment strategies.
The prevalence of bile duct cancer has risen significantly in recent years. According to the American Cancer Society, approximately 8,000 new cases are diagnosed annually in the United States. Similarly, the Christie NHS Foundation Trust in the UK reports around 1,000 cases each year.
Geographical Outlook

North America Expected to Dominate: The North American region is anticipated to hold a significant share of the global cholangioscopy market during the forecast period. This growth is attributed to the increasing adoption of advanced technologies within the healthcare sector. North America is a leader in research and development efforts aimed at enhancing cholangioscopic equipment performance. Furthermore, countries like the USA and Canada have implemented key policies and investment opportunities to expand access to advanced technologies in the pharmaceutical sector.

Reasons for buying this report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.

Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.

Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.

Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.

Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2030

Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis

Competitive Positioning, Strategies, and Market Share Analysis

Revenue Growth and Forecast Assessment of segments and regions including countries

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)
The Cholangioscopy Market is segmented and analyzed as:

By Type

Peroral Videocholangioscopy (POCS)
Direct Peroral Videocholangioscopy (D-POCS)
SpyGlass™ Direct Visualization System (SGDVS)
Others

By Equipment Type

Endoscope
Duodenoscope
Others

By Application

Diagnostics
Post–liver transplant
Choledocholithiasis
Intraductal tumor mapping
Others
Therapeutics
Lithotripsy
Biliary tumor ablative therapy
Selective biliary duct wire cannulation

By Technology

High Definition Systems
Digital Imaging Technologies

By End User

Hospitals
Surgical Centers

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Italy
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific Region
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Others

1. INTRODUCTION: 1.1. Market Overview; 1.2. Market Definition; 1.3. Scope of the Study; 1.4. Market Segmentation; 1.5. Currency; 1.6. Assumptions; 1.7. Base and Forecast Years Timeline; 1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY: 2.1. Research Design; 2.2. Research Process
3. EXECUTIVE SUMMARY: 3.1. Key Findings
4. MARKET DYNAMICS: 4.1. Market Drivers; 4.2. Market Restraints; 4.3. Porter’s Five Forces Analysis; 4.3.1. Bargaining Power of Suppliers; 4.3.2. Bargaining Power of Buyers; 4.3.3. The Threat of New Entrants; 4.3.4. Threat of Substitutes; 4.3.5. Competitive Rivalry in the Industry; 4.4. Industry Value Chain Analysis; 4.5. Analyst View
5. CHOLANGIOSCOPY SAUCE MARKET BY TYPE: 5.1. Introduction; 5.2. Peroral Videocholangioscopy (POCS); 5.3. Direct Peroral Videocholangioscopy (D-POCS); 5.4. SpyGlass Direct Visualization System (SGDVS); 5.5. Others
6. CHOLANGIOSCOPY SAUCE MARKET BY EQUIPMENT TYPE: 6.1. Introduction; 6.2. Endoscope; 6.3. Duodenoscope; 6.4. Others
7. CHOLANGIOSCOPY MARKET BY APPLICATION: 7.1. Introduction; 7.2. Diagnostics; 7.2.1. Post–liver transplant; 7.2.2. Choledocholithiasis; 7.2.3. Intraductal tumor mapping; 7.2.4. Others; 7.3. Therapeutics; 7.3.1. Lithotripsy; 7.3.2. Biliary tumor ablative therapy; 7.3.3. Selective biliary duct wire cannulation; 7.3.4. Others
8. CHOLANGIOSCOPY MARKET BY TECHNOLOGY: 8.1. Introduction; 8.2. High Definition Systems; 8.3. Digital Imaging Technologies
9. CHOLANGIOSCOPY MARKET BY END-USER: 9.1. Introduction; 9.2. Hospitals; 9.3. Surgical Centers
10. CHOLANGIOSCOPY MARKET BY GEOGRAPHY: 10.1. Introduction; 10.2. North America; 10.2.1. By Type; 10.2.2. By Equipment Type; 10.2.3. By Application; 10.2.4. By Technology; 10.2.5. By End-User; 10.2.6. By Country; 10.2.6.1. United States; 10.2.6.2. Canada; 10.2.6.3. Mexico; 10.3. South America; 10.3.1. By Type; 10.3.2. By Equipment Type; 10.3.3. By Application; 10.3.4. By Technology; 10.3.5. By End-User; 10.3.6. By Country; 10.3.6.1. Brazil; 10.3.6.2. Argentina; 10.3.6.3. Others; 10.4. Europe; 10.4.1. By Type; 10.4.2. By Equipment Type; 10.4.3. By Application; 10.4.4. By Technology; 10.4.5. By End-User; 10.4.6. By Country; 10.4.6.1. Germany; 10.4.6.2. Spain; 10.4.6.3. United Kingdom; 10.4.6.4. France; 10.4.6.5. Others; 10.5. Middle East and Africa; 10.5.1. By Type; 10.5.2. By Equipment Type; 10.5.3. By Application; 10.5.4. By Technology; 10.5.5. By End-User; 10.5.6. By Country; 10.5.6.1. Saudi Arabia; 10.5.6.2. UAE; 10.5.6.3. Israel; 10.5.6.4. Others; 10.6. Asia Pacific; 10.6.1. By Type; 10.6.2. By Equipment Type; 10.6.3. By Application; 10.6.4. By Technology; 10.6.5. By End-User; 10.6.6. By Country; 10.6.6.1. Japan; 10.6.6.2. China; 10.6.6.3. India; 10.6.6.4. South Korea; 10.6.6.5. Indonesia; 10.6.6.6. Thailand; 10.6.6.7. Taiwan; 10.6.6.8. Others
11. COMPETITIVE ENVIRONMENT AND ANALYSIS: 11.1. Major Players and Strategy Analysis; 11.2. Market Share Analysis; 11.3. Mergers, Acquisitions, Agreements, and Collaborations; 11.4. Competitive Dashboard
12. COMPANY PROFILES: 12.1. Boston Scientific Corporation; 12.2. Micro-Tech Endoscopy; 12.3. Japan Lifeline Co., Ltd.; 12.4. Ottomed; 12.5. Olympus Corporation; 12.6. Penlon; 12.7. Fujifilm Group; 12.8. Medtronic; 12.9. Johnson & Johnson; 12.10. Cook Medical, Inc.; 12.11. B. Braun Melsungen AG; 12.12. Arthrex, Inc.; 12.13. HOYA Corporation